Lymphomas during long-term methotrexate therapy.
Kamel
O W
OW
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004854:Herpesvirus 4, Human / Q000502:physiology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008223:Lymphoma / Q000209:etiology* / Q000821:virology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate